Business · 1 sources covering this

Many bought this stock to play the GLP-1 boom, but it has bigger opportunities to boost its share price

Instead of betting on which single pharmaceutical company wins a drug race, this company benefits as the industry grows by supplying the proprietary packaging.

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

0 L · 0 C · 1 R

How 1 sources are covering this

CNBCLean R·2h ago
Many bought this stock to play the GLP-1 boom, but it has bigger opportunities to boost its share price
Instead of betting on which single pharmaceutical company wins a drug race, this company benefits as the industry grows by supplying the proprietary packaging.
Read at CNBC →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/77d2209fdc7974fb524a6ed4338bc38aae2ed2a1"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Many bought this stock to play the GLP-1 boom, but it has bigger opportunities to boost its share price"></iframe>

Many bought this stock to play the GLP-1 boom, but it has bigger opportunities to boost its share price

How 1 sources are covering this

Many bought this stock to play the GLP-1 boom, but it has bigger opportunities to boost its share price

More from Business

How China’s A.I. Is Surging Across Africa

Google's AI reshuffle: Chief scientist Jeff Dean exits and Demis Hassabis steps down as DeepMind CEO

Iran, Oman say Strait of Hormuz talks in final stages, as Trump again teases a deal being close

Abdul El-Sayed wins Michigan Democratic Senate primary as voters pivot to the left

Reader

Trust & legal

Across the network